An innovative IVD antibody development platform has been designed by our scientists to facilitate the identification and synthesis of high-affinity and high-specificity monoclonal and polyclonal antibodies (mAbs). IVD mAbs antibody discovery has made use of a variety of state-of-the-art technologies, including hybridoma, antigen-specific single B cell sorting, and display technologies like phage, mammalian cell, and yeast display. Following that, a variety of expression methods are available for the synthesis of superior IVD antibodies, including yeast, bacteria, mammalian cells, baculoviral insect cells, plant expression systems, and cell-free systems.
Learn more: https://www.creative-biola...